Mechanistic modelling of bioavailability and local immunogenicity after subcutaneous administration within the Open Systems Pharmacology framework

PBPK & PBBM

QSP

Immunology

PAGE 31 (2023) Abstr 10497

Pellowe M, Selvaggio G, Chenel M, Sjögren E